Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio as a novel predictor of long-term ischemic heart disease risk in overweight men: a nationwide population-based study

Background: The gamma-glutamyl transferase to high-density lipoprotein cholesterol (GGT/HDL-c) ratio is a novel composite index reflecting systemic oxidative stress and metabolic dysfunction. However, its prognostic value for long-term ischemic heart disease (IHD) risk among overweight men—a population with highly heterogeneous metabolic profiles—remains largely unexplored. This study investigated the association between the GGT/HDL-c ratio and incident IHD in this high-risk group. Methods: This retrospective, population-based cohort study utilized data from the Korean National Health Insurance Service. A total of 124,044 overweight men (body mass index ≥23.0 kg/m2) without a history of ischemic heart disease were included and stratified into quartiles according to their GGT/HDL-c ratios. Multivariate Cox proportional hazards regression models were used to estimate hazard ratios (HRs) for incident IHD. The incremental predictive value was evaluated using the C-index and net reclassification improvement (NRI). Results: Over a follow-up period of up to 20 years among the 124,044 participants, those in the highest GGT/HDL-c quartile (Q4) exhibited a significantly increased risk of IHD compared to the lowest quartile (Q1) (fully adjusted HR, 1.65; 95% confidence interval (CI), 1.49–1.83). A significant interaction with physical activity was observed (p < 0.001); the elevated IHD risk in Q4 was more pronounced among physically inactive men (HR, 1.82; 95% CI, 1.61–2.06) than among those engaging in regular exercise (HR, 1.42; 95% CI, 1.21–1.67). The addition of the GGT/HDL-c ratio to traditional risk models significantly improved risk reclassification (NRI = 0.058). Conclusions: An elevated GGT/HDL-c ratio is a potent and independent predictor of IHD in overweight men. Integrating this simple, cost-effective biomarker into routine assessments may improve clinical risk stratification. Furthermore, regular physical activity may serve as an important intervention to mitigate the elevated cardiovascular risk associated with this metabolic imbalance.

Gamma-glutamyl transferase; High-density lipoprotein cholesterol; GGT/HDL-c ratio; Ischemic heart disease; Overweight; Oxidative stress; Physical activity; Cohort study

[1] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. The Lancet. 2017; 390: 2627–2642.

[2] Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al.; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021; 143: e984–e1010.

[3] Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012; 126: 1301–1313.

[4] Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, et al.; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. The Lancet Diabetes & Endocrinology. 2019; 7: 715–725.

[5] Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. The Lancet Diabetes & Endocrinology. 2013; 1: 152–162.

[6] Whitfield JB. Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences. 2001; 38: 263–355.

[7] Lee DH, Blomhoff R, Jacobs DR III. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radical Research. 2004; 38: 535–539.

[8] Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation. 2005; 112: 2078–2080.

[9] Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. The New England Journal of Medicine. 2010; 363: 1341–1350.

[10] Rader DJ, Hovingh GK. HDL and cardiovascular disease. The Lancet. 2014; 384: 618–625.

[11] Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. The New England Journal of Medicine. 2014; 371: 2383–2393.

[12] Feng G, Feng L, Zhao Y. Association between ratio of γ-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study. Annals of Translational Medicine. 2020; 8: 634.

[13] Xie W, Liu B, Tang Y, Yang T, Song Z. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio: a valuable predictor of type 2 diabetes mellitus incidence. Frontiers in Endocrinology. 2022; 13: 1026791.

[14] He L, Chen S, Zhu X, He F. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio: a valuable predictor of coronary heart disease incidence. Nutrition, Metabolism and Cardiovascular Diseases. 2025; 35: 103775.

[15] Qiu S, Li C, Guo Z. The J-shaped relationship between the gamma-glutamyltransferase to high-density lipoprotein cholesterol ratio and mortality risk in U.S. adults. Preventive Medicine Reports. 2025; 52: 102958.

[16] Pompella A, Corti A, Paolicchi A, Giommarelli C, Zunino F. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Current Opinion in Pharmacology. 2007; 7: 360–366.

[17] Ndrepepa G, Kastrati A. Gamma-glutamyltransferase and cardiovascular disease. Annals of Translational Medicine. 2016; 4: 481.

[18] Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circulation Research. 2004; 95: 764–772.

[19] Jung DH, Park B, Ryu HE, Lee YJ. Sex-specific associations of γ-glutamyltransferase to HDL-cholesterol ratio and the incident risk of cardiovascular disease: three Korean longitudinal cohorts from different regions. Frontiers in Endocrinology. 2023; 14: 1231502.

[20] Finaud J, Lac G, Filaire E. Oxidative stress: relationship with exercise and training. Sports Medicine. 2006; 36: 327–358.

[21] Goff DC III, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: S49–S73.